Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 451-500 of 1158 result(s).
CYDY CytoDyn Inc
11/10/2024 12:53:42 AM
May 2022 on Pestell: Dr. Pestell an (7)
CYDY CytoDyn Inc
11/10/2024 12:10:34 AM
Breast Cancer & Cytodyn: Our Dr. Ue (7)
CYDY CytoDyn Inc
11/09/2024 11:03:15 AM
Him moving from Covid/HIV....into t (1)
CYDY CytoDyn Inc
11/09/2024 12:12:15 AM
Did not realize GSK's R&D focus is (5)
CYDY CytoDyn Inc
11/08/2024 10:40:57 PM
This part: Chronic immunosuppressio (1)
CYDY CytoDyn Inc
11/08/2024 7:08:58 PM
Forgot his UCLA bio: A more recent (1)
CYDY CytoDyn Inc
11/08/2024 6:36:11 PM
Our Dr. Otto Yang profile: He then (8)
CYDY CytoDyn Inc
11/07/2024 7:12:50 PM
She left L'oreal for GlaxoSmithKlin (5)
CYDY CytoDyn Inc
11/07/2024 5:44:53 PM
Sean, GSK CEO E. Walmsley... Sept. (3)
CYDY CytoDyn Inc
11/06/2024 6:19:31 AM
MD/GSK/AISC: 2013: Oncology Clinica (7)
CYDY CytoDyn Inc
11/05/2024 10:04:12 PM
July 15, 2024 The University of Tex (2)
CYDY CytoDyn Inc
11/05/2024 7:51:51 PM
The University of Texas MD Anderson (2)
CYDY CytoDyn Inc
11/05/2024 9:00:56 AM
Yes they do. Unreal & the last SH L (8)
CYDY CytoDyn Inc
11/05/2024 8:39:28 AM
New SAB member: Clinton Yam, MD, MS (19)
CYDY CytoDyn Inc
11/05/2024 2:39:51 AM
" Even in that small of a trial we (1)
CYDY CytoDyn Inc
11/05/2024 12:06:38 AM
Surrogate reads like anecdotal is b (1)
CYDY CytoDyn Inc
11/04/2024 11:30:40 PM
Saying it's not unmet need ? There (3)
CYDY CytoDyn Inc
11/04/2024 9:45:02 PM
A surrogate endpoint.... The FDA in (4)
CYDY CytoDyn Inc
11/04/2024 8:27:47 PM
While the FDA does not typically gr (3)
CYDY CytoDyn Inc
11/04/2024 7:44:32 PM
On that there was a post showing a
CYDY CytoDyn Inc
11/04/2024 7:12:50 PM
1 thing I noticed a little while ag (2)
CYDY CytoDyn Inc
11/04/2024 6:58:36 PM
Don't forget Aug. 2024: " This open (5)
CYDY CytoDyn Inc
11/04/2024 6:04:05 PM
Syneos oncology since 2019. Click o (7)
CYDY CytoDyn Inc
11/04/2024 4:36:26 PM
Yea & very likely the norm across h
CYDY CytoDyn Inc
11/04/2024 3:06:47 PM
CRC -- my bet is interim look. (7)
CYDY CytoDyn Inc
11/04/2024 10:14:21 AM
No surprise -- Relieved. : ) (4)
CYDY CytoDyn Inc
11/04/2024 9:30:21 AM
Max is getting busier & busier in s (5)
CYDY CytoDyn Inc
11/04/2024 9:12:12 AM
A clinical trial kickoff meeting (K (10)
CYDY CytoDyn Inc
11/03/2024 12:07:28 AM
LL / CCL4: Jan. 2021. "Leronlimab b (6)
CYDY CytoDyn Inc
11/02/2024 7:31:19 PM
Forgot Ai excerpt: Some of the top (2)
CYDY CytoDyn Inc
11/02/2024 7:27:34 PM
ASC30 / Orforglipron: Orforglipron (3)
CYDY CytoDyn Inc
10/31/2024 9:11:17 PM
Dr. Palmer / Ascletis : *Gannex, a (9)
CYDY CytoDyn Inc
10/31/2024 3:36:56 PM
Wonder If Dr. Palmer has been tinke
CYDY CytoDyn Inc
10/31/2024 12:25:17 AM
9/24: Recommendations for detection
CYDY CytoDyn Inc
10/30/2024 10:58:32 PM
The no new shares requested. Today (1)
CYDY CytoDyn Inc
10/30/2024 10:42:49 PM
It's a good structure & not a crazy (2)
CYDY CytoDyn Inc
10/30/2024 8:03:46 PM
Thx Plotinus!
CYDY CytoDyn Inc
10/30/2024 7:58:34 PM
Dr. Palmer extra bio info: for all (2)
CYDY CytoDyn Inc
10/30/2024 11:46:52 AM
From Reddit: BuildGoodThings • 23 (11)
CYDY CytoDyn Inc
10/30/2024 10:47:19 AM
Overview of Causality Assessment fo (4)
CYDY CytoDyn Inc
10/30/2024 12:51:05 AM
Neuroradiological measurements for (5)
CYDY CytoDyn Inc
10/29/2024 11:59:27 PM
Absolutely way beyond anything I ca
CYDY CytoDyn Inc
10/29/2024 11:59:44 AM
May 2024 on dilution: https://inves (5)
CYDY CytoDyn Inc
10/29/2024 10:47:45 AM
Aren't you projecting on things not (4)
CYDY CytoDyn Inc
10/29/2024 8:54:43 AM
I also look to future potentials. J (4)
CYDY CytoDyn Inc
10/29/2024 8:34:26 AM
Private subsidiary & the only 2 sha (1)
CYDY CytoDyn Inc
10/29/2024 8:19:06 AM
Ram, the platform drug is even bigg (2)
CYDY CytoDyn Inc
10/29/2024 7:39:15 AM
That cleans up "Cytodyn" past optic (5)
CYDY CytoDyn Inc
10/28/2024 10:39:19 PM
Maybe: GSK/Pfizer ipo's our non-hiv (3)
CYDY CytoDyn Inc
10/28/2024 1:12:19 AM
Material and financial support for
Go to page:
  • << First
  • < Previous
  • 9
  • 10
  • Next >

Recent Articles

  • Smartee Denti-Technology Establishes Partnership with Renowned University
  • BlackRock's Significant Stake Increase in Syensqo Explained
  • Bekaert's Strategic Share Buyback and Liquidity Initiatives
  • Electrolux Group Invites You to Their Q2 Results Presentation
  • Electrolux Group Announces Q2 2025 Results Presentation Invitation
  • Author of Bestselling Memoir Faces Legal Challenges Ahead
  • La Rosa Holdings Faces Volatility After Revenue Surge
  • Ping An Good Doctor Leverages AI for Revolutionary Healthcare Solutions
  • Electrolux Group Invites You to Q2 Results Presentation
  • Araris Biotech Team Receives 2025 Strüngmann Award Recognition
  • Bekaert's Commitment to Shareholder Value Through Buybacks
  • Orion Corporation Announces Financial Insights and Upcoming Webcast
  • Investing Insights: NB Private Equity Partners' Share Buyback
  • Eurocastle's Financial Highlights and Strategic Initiatives
  • OSB Group PLC Achieves Key Milestone in Share Buyback Program
  • Diversified Energy's Strategic Share Buyback Enhances Value
  • NB Private Equity Partners Declares 2H 2025 Dividend Payment
  • Foresight Group Holdings Announces Share Buyback Strategy
  • IDEX Biometrics ASA Implements Share Consolidation Today
  • SATO Corporation Expands Portfolio with New Apartments
  • AB Science's Masitinib: A New Hope for Prostate Cancer Patients
  • NB Private Equity Partners Highlights Upcoming Dividend for Shareholders
  • Eurocastle Updates Strategies and Financial Position for 2025
  • IDEX Biometrics ASA: Key Changes to Share Structure Announced
  • Masitinib Gains Crucial Approvals for Advanced Prostate Cancer Trial
  • Alstom Secures Major Contract for M-9A Railcars at €2 Billion
  • Aker BP Takes Strides: Key Insights from Q2 2025 Update
  • Aker BP Releases Insights on Q2 2025 Production Figures
  • Alstom's Significant €2.0 Billion Order for M-9A Railcars
  • ISS Secures Major Contract for Public Healthcare Services
  • Air France-KLM Moves Towards Control of Scandinavian Airline SAS
  • Air France-KLM's Strategic Move to Increase SAS Stake
  • ISS Secures Major Contract to Enhance Healthcare Services
  • Jane Street Faces Regulatory Actions Amid Trading Allegations
  • Lerøy Seafood Group's Impressive Q2 2025 Harvest Insights
  • Impressive Growth in Lerøy Seafood Group's Q2 Harvest Volumes
  • Exciting Highlights from the Spectacular Golden Melody Awards
  • Elon Musk's xAI Receives Permit for Turbines Despite Backlash
  • Cryptocurrency Market Reactions to Trump's Legislative Success
  • Sonnet BioTherapeutics Stock Recovery Highlights Market Volatility
  • Unlocking High-Yield Income: BTC Miner Empowers Investors
  • Why Staying at One Job Longer Can Be Beneficial
  • Starlight Retail Expands Cloud Services with Google Partnership
  • Discover the Unique Benefits of THCA Snow Caps Flower Today
  • High-Net-Worth Investors Seek BTC Miner for Reliable Income
  • Rising Star: Jensen Huang Sees $25 Billion Increase in Wealth
  • Fujitsu's New AI Solution to Revolutionize Supply Chains
  • Recent Passenger Traffic Trends for Grupo Aeroportuario del Pacífico
  • World Trading Tournament Shifts Dates and Introduces Mini Events
  • Trending Technology Stocks To Watch Based on Recent Market Moves
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site